Enter your search terms:
Top

Uncategorized

MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance

Industry Veteran to Support Rapidly Advancing Pipeline Warren, NJ (June 17, 2010) – MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the appointment of Mary Ellen Norvitch, Ph.D. to the newly created position of Vice President, Regulatory Affairs/Clinical Affairs/Quality Assurance.  Effective immediately, Dr. Norvitch will...

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

Warren, NJ (April 9, 2009) – MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced the submission on April 7, 2009...